How insurance coverage shapes access to kidney transplantation
· Medical Xpressedited by Swati Mestri, reviewed by Andrew Zinin
Swati Mestri
Scientific Editor
Meet our editorial team
Behind our editorial process
Andrew Zinin
Chief Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
The GIST Add to Preferred Sources
For people with kidney failure, access to transplantation can mean better survival and quality of life.
A study published in JAMA raises questions about whether patients have comparable access across Medicare coverage options.
The Brown University–led study examined 630,848 Medicare beneficiaries with end-stage kidney disease from 2021 through 2023. After adjusting for measured differences between patients, researchers found that Medicare Advantage enrollees had a 29% lower rate of kidney transplantation and a 23% lower rate of being newly placed on a transplant waiting list than traditional Medicare beneficiaries.
Regenstrief-affiliated researchers Kelsey Drewry, Ph.D., M.A., Adam Wilk, Ph.D., and Rachel Patzer, Ph.D., M.P.H., contributed to the research. Patzer and Drewry helped develop the study's concept and design, and all three contributed to its data acquisition, analysis or interpretation and critical manuscript review. Patzer also helped secure funding and supervise the work.
The findings highlight an important policy question: How can expanded insurance options translate into meaningful access to treatment?
The study followed a federal policy change that expanded Medicare Advantage eligibility for people with end-stage kidney disease in 2021. Although the findings do not establish that Medicare Advantage caused the differences, they support closer monitoring of transplant access and further examination of potential barriers, including provider networks and prior authorization.
Publication details
Ankur D. Shah et al., Medicare Advantage Enrollment and Access to Kidney Transplant After the 21st Century Cures Act, JAMA (2026). DOI: 10.1001/jama.2026.14391
Journal information: Journal of the American Medical Association
Key medical concepts
Kidney TransplantationKidney Failure, Chronic
Clinical categories
Nephrology Provided by Regenstrief Institute Who's behind this story?
Swati Mestri
Swati Mestri holds a bachelor's degree in Electronics Engineering and has worked as a content editor since 2019. She has experience editing research documents across technology, health care, and materials science, and has a particular interest in technology and space. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: How insurance coverage shapes access to kidney transplantation (2026, October 29) retrieved 30 October 2026 from https://medicalxpress.com/news/2026-10-coverage-access-kidney-transplantation.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.